GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM39509
Query DataSets for GSM39509
Status
Public on Apr 01, 2005
Title
ms41-2
Sample type
RNA
Source name
Staged C. elegans embryos
Organism
Caenorhabditis elegans
Extracted molecule
total RNA
Description
Mutant genotype mex-3(zu155); skn-1(RNAi) 41 minutes after the 4-cell embryonic stage at 22 degrees C
Sample_genotype: ms
Sample_time: 41
Submission date
Jan 24, 2005
Last update date
May 27, 2005
Contact name
Andrew Hill
E-mail(s)
andrew.hill@pfizer.com
Phone
617-674-6341
Organization name
Pfizer
Department
Research Business Technology
Street address
300 Technology Square
City
Cambridge
State/province
MA
ZIP/Postal code
02139
Country
USA
Platform ID
GPL200
Series (1)
GSE2180
C. elegans embryonic timecourse in wt and mutant embryos
Data table header descriptions
ID_REF
Affymetrix Qualifier
VALUE
RMA calulated using Bioconductor Affy package (http://www.bioconductor.org)
Data table
ID_REF
VALUE
171720_x_at
5.77386714122948
171721_x_at
5.73690576511756
171722_x_at
5.94185819520831
171723_x_at
3.44570342189271
171724_x_at
6.77267853871219
171725_x_at
4.06612328929193
171726_x_at
4.47920832472856
171727_x_at
2.6806200913659
171728_x_at
3.17377153824337
171729_x_at
6.03801631246061
171730_x_at
2.81606453828130
171731_x_at
7.67920748282382
171732_x_at
5.71433576974383
171733_x_at
3.80024125977265
171734_x_at
10.1272951432369
171735_x_at
2.73059219321587
171736_x_at
6.34132850474533
171737_x_at
4.42794119348217
171738_x_at
4.74139005707485
171739_x_at
3.56185607213887
Total number of rows:
22625
Table truncated, full table size
608 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM39509.CEL.gz
2.7 Mb
(ftp)
(http)
CEL
GSM39509.EXP.gz
330 b
(ftp)
(http)
EXP
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|
